arrow
返回

'Dark matter', second waves and epidemiological modelling

delete2020-12-15
delete8
delete
OA
AI
K
Karl Friston *
A
Anthony Costello
D
Deenan Pillay
DOI:10.1136/bmjgh-2020-003978delete
delete原文链接
delete分享
delete收藏
查看原文
摘要

摘要

En 中文
Recent reports using conventional Susceptible, Exposed, Infected and Removed models suggest that the next wave of the COVID-19 pandemic in the UK could overwhelm health services, with fatalities exceeding the first wave. We used Bayesian model comparison to revisit these conclusions, allowing for heterogeneity of exposure, susceptibility and transmission. We used dynamic causal modelling to estimate the evidence for alternative models of daily cases and deaths from the USA, the UK, Brazil, Italy, France, Spain, Mexico, Belgium, Germany and Canada over the period 25 January 2020 to 15 June 2020. These data were used to estimate the proportions of people (i) not exposed to the virus, (ii) not susceptible to infection when exposed and (iii) not infectious when susceptible to infection. Bayesian model comparison furnished overwhelming evidence for heterogeneity of exposure, susceptibility and transmission. Furthermore, both lockdown and the build-up of population immunity contributed to viral transmission in all but one country. Small variations in heterogeneity were sufficient to explain large differences in mortality rates. The best model of UK data predicts a second surge of fatalities will be much less than the first peak. The size of the second wave depends sensitively on the loss of immunity and the efficacy of Find-Test-Trace-Isolate-Support programmes. In summary, accounting for heterogeneity of exposure, susceptibility and transmission suggests that the next wave of the SARS-CoV-2 pandemic will be much smaller than conventional models predict, with less economic and health disruption. This heterogeneity means that seroprevalence underestimates effective herd immunity and, crucially, the potential of public health programmes.
Keyword:
epidemiology
mathematical modelling
AI总结

AI总结

对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。

期刊

B
BMJ Global Health
IF:
6.1
论文数:
3.9K
被引数:
1.6W

机构

U
University College London
学者数:
7.9W
论文数: 6.2W
被引数: 15.7W
U
university of london
学者数:
21.5W
论文数: 19.7W
被引数: 305
引用论文

引用论文

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China武汉地区2019例新型冠状病毒感染患者临床特征分析
errLANCET
IF88.5
err2020-02-01
err2.7W
errOAAI
errHuang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin
err分享
err收藏
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
err2020-06-18
err1.9K
errOAAI
errLong, Quan-Xin; Tang, Xiao-Jun; Shi, Qiu-Lin; Li, Qin; Deng, Hai-Jun; Yuan, Jun; Hu, Jie-Li; Xu, Wei; Zhang, Yong; Lv, Fa-Jin; Su, Kun; Zhang, Fan; Gong, Jiang; Wu, Bo; Liu, Xia-Mao; Li, Jin-Jing; Qiu, Jing-Fu; Chen, Juan; Huang, Ai-Long
err分享
err收藏
Supplementary Materials from METTL1-Mediated m<sup>7</sup>G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma
err
IF0
err2023-03-31
err0
errOAAI
errManling Huang; Jianting Long; Zhijia Yao; Yi Zhao; Yutong Zhao; Junbin Liao; Kai Lei; Han Xiao; Zihao Dai; Sui Peng; Shuibin Lin; Lixia Xu; Ming Kuang
err分享
err收藏
MicroRNA Profiling in Human Neutrophils during Bone Marrow Granulopoiesis and In Vivo Exudation
err2013-03-12
err0
errOAAI
errMaria T. Larsen; Christoffer Hother; Mattias Häger; Corinna C. Pedersen; Kim Theilgaard-Mönch; Niels Borregaard; Jack B. Cowland
err分享
err收藏
The role of innate lymphoid cells in response to microbes at mucosal surfaces
err2020-05-01
err39
errOAAI
errSeo, Goo-Young; Giles, Daniel A.; Kronenberg, Mitchell
err分享
err收藏
学者 查看更多内容